- OncoSec Medical (NASDAQ:ONCS) 9M'15 results: Revenues: $0; R&D Expense: $9.3M (+138.5%); SG&A: $5.4M (+20.0%); Net Loss: ($14.7M) (-72.9%); Loss Per Share: ($1.19) (-24.0%); Quick Assets: $25.4M (-33.0%).
- No guidance given.
OncoSec Medical reports 9M15 results
Recommended For You
More Trending News
About ONCSQ Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ONCSQ | - | - |
| OncoSec Medical Incorporated | ||